Developer of immersive therapeutics, including the prescription-use RelieVRx system for chronic lower-back pain.
Evidence and ecosystem, in one view.
Browse reviewed public metadata. Trust labels describe provenance—not clinical endorsement.
Catalog
Search by clinical need, modality, organization, or use case. Every result shows its source and review state.
Healthcare procedural-skills training platform offering VR scenarios, assessment, collaboration, and learning-management tools.
A VR and mobile training platform focused on surgical skills, case practice, feedback, and institution-level learning insights.
Developer of immersive training experiences spanning virtual and mixed reality for clinical and procedural learning.
Healthcare-first clinical simulation delivered through VR headsets or standard screens, with customizable scenarios and learning analytics.
Immersive virtual-patient encounters for clinical teams, with multiplayer simulation and configurable scenarios across care environments.
Transforms medical imaging into interactive 3D models for surgical planning, rehearsal, patient engagement, and intraoperative XR visualization.
An XR healthcare platform connecting immersive applications with clinician workflows and remote therapeutic services.
A prescription-use immersive VR system providing adjunctive, skills-based treatment for adults with chronic lower-back pain.
FDA summary describing RelieVRx, its intended use, device classification, and relationship to the predicate device.
A 2025 article tracing development, authorization, and implementation considerations for a VR-delivered chronic lower-back-pain program.
Research exploring XR devices, haptics, motor learning, sensorimotor coordination, and medical-training applications.
A European XR industry conference and expo. AVRMD tracks it as a broad ecosystem event rather than a medical-only conference.
An IEEE COMPSAC workshop focused on AR, VR, XR, AI-driven immersive visualization, medical imaging, and clinical applications.
A standalone virtual and mixed reality headset with full-colour passthrough and inside-out tracking, requiring no external sensors or tethered computer.
A head-worn spatial computer blending digital content with the wearer's surroundings, controlled by eye, hand, and voice input.
A standalone enterprise virtual reality headset with eye tracking and colour passthrough, positioned for organisational training and simulation deployments.
A professional mixed reality headset built for high visual fidelity, aimed at simulation, training, and engineering work where display detail matters.
Children undergoing short but painful procedures experience distress that sedation cannot always address, and fear compounds the pain itself.
In crises such as vaso-occlusive episodes, pain is severe and escalating analgesia carries its own risks, leaving a gap for non-pharmacological adjuncts.
Multi-week self-directed therapy works only if patients keep going after the first fortnight, and drop-off is the usual outcome.
A scenario that works for six learners rarely survives contact with a cohort of three hundred, once headset supply, cleaning, and timetabling are counted.
Higher fidelity costs more and is assumed to teach better, but which cues change behaviour — and which are decoration — is rarely tested.
The events that most need practice — outbreaks, mass casualties, rare deteriorations — are precisely the ones a rota cannot produce on demand.
Procedural competence needs repetition, but theatre time, cadaveric material, and supervision are all scarce and unevenly distributed.
Competence is still largely judged by observation, which is expensive, inconsistent between assessors, and hard to schedule.
Recovery needs many repetitions of movement that is difficult, tiring, and unrewarding to perform, so adherence and intensity both suffer.
Findings about how movement is relearned are well established in the laboratory and slow to reach the treatment room.
Moving therapy into the home removes travel but also removes the clinician, leaving technique uncorrected and progress unmeasured.
Every proposal adds teaching to a saturated timetable; the harder question is what comes out, and how that is defended to faculty.
Demand for responders spikes exactly when trainers are least available, and conventional courses do not scale to meet it.
A plan built from imaging has to be carried into theatre and aligned with the patient on the table, where attention and sterile field both constrain how it can be shown.
Interactive three-dimensional models are compelling in demonstration; producing one for an urgent case depends on segmentation staffing, not software.
Developer of augmented and mixed reality visualisation for cardiac electrophysiology, including an FDA-cleared platform that renders real-time catheter data as a hands-free 3D hologram.
Developer of VR-delivered psychological treatments guided by a virtual coach, targeting conditions ranging from anxiety to psychosis.
VR therapy platform delivering structured social and communication practice for neurodiverse learners, delivered on headsets, phones, or a browser.
Provider of a twelve-week chronic pain programme combining virtual reality with personalised behavioural coaching, aimed at restoring function.
Manufacturer of virtual surgical simulators with haptic feedback for ear, sinus, and dental procedures, intended to reduce reliance on human specimens for training.
Developer of biosensor-enabled VR environments for procedural and chronic pain, including a biofeedback experience driven by heart-rate monitoring.
Developer of neurorehabilitation systems combining immersive software, smart peripherals, and motion analytics for recovery after stroke and other neurological conditions.
Medical simulation company supplying surgical and ultrasound training simulators, and the acquirer of Intelligent Ultrasound's simulation business in 2025.
Developer of ultrasound training simulators and clinical image-recognition software. The company was split and sold: its clinical AI business to GE HealthCare in 2024, its simulation business to Surgical Science in 2025.
Developer of evidence-based digital therapeutics for adolescent mental health, including the SparkRx programme. Acquired by Big Health in July 2023.
Stanford University laboratory studying the psychological and behavioural effects of virtual and augmented reality, founded in 2003.
Free, open-source software for visualisation, segmentation, registration, and analysis of medical images, with extensions for viewing and interacting with scenes in virtual reality.
Open-source framework for real-time physics simulation, widely used as the engine underneath medical simulation and surgical training research.
A see-through augmented reality headset with dimming technology, marketed for enterprise use including healthcare and surgical visualisation settings.
The IEEE Conference on Virtual Reality and 3D User Interfaces, described by its organisers as the premier international venue for advances in virtual, augmented, and mixed reality. Hosts the XR Health workshop track.
The International Symposium on Mixed and Augmented Reality, the leading academic venue for AR and MR research, organised by IEEE and ACM SIGCHI.
An augmented overlay is only useful if it sits exactly where the anatomy is. Registration has to survive patient movement, soft-tissue shift, and a surgeon's changing viewpoint, and the error budget is millimetres.
Visual realism has advanced far faster than touch. Without convincing resistance and texture, a simulator teaches the sequence of a procedure but not the feel of it, which is much of the skill.
Delay between hand and image is tolerable when watching, but not when operating. Small amounts of lag measurably reduce precision and raise cognitive load, and the effect compounds the longer someone works.
Headsets record rich data — gaze, movement, timing — and it is tempting to treat it as assessment. Establishing that those numbers correspond to real clinical ability is a separate and harder task.
Hardware turns over faster than clinical software can be revalidated. Without a portable target, each new device risks a rebuild — a serious cost when the software is a regulated medical product.
A 510(k) depends on showing equivalence to a legally marketed device, but a headset-delivered therapy or overlay often differs from older products in design, display and software. Choosing a predicate that holds up, and arguing the differences do not change safety or effectiveness, is a recurring hurdle.
Medical XR software runs on consumer-grade headsets whose operating system and firmware change on the platform vendor's schedule. Each change can alter rendering, tracking or timing, and manufacturers must decide what needs re-verification and what a pre-agreed change plan can cover.
The FDA lists cybersecurity and privacy among the probable risks of AR/VR medical devices but sets no headset-specific controls, so each manufacturer has to decide what sensor data to collect and how to protect it.
A participant inside a headset knows whether the experience is therapeutic, so convincing placebo conditions and masking are hard to build. Trials often settle for blinding only the analysts, which leaves room for expectation effects.
Session length, weekly frequency and total course vary widely between VR trials, and the best-performing settings differ by outcome and population. Without a standard dose, studies are hard to compare and a product's labelled regimen is hard to justify.
Many VR studies measure change during or just after exposure. Evidence that effects persist weeks later, especially for chronic conditions, is thinner and inconsistent, which limits clinical and payer confidence.